Apellis Pharmaceuticals (APLS) Q2 2023 Earnings

31JulConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-1.75
-1.51
-1.26
-1.02

Details

Expected EPS
-1.32
Actual EPS
-1.02
Surprise EPS
0.3
Surprise Percent
+22.73%

Description

Apellis Pharmaceuticals (APLS) has reported earnings of -1.02 per share for Q2 2023.

0 Comments

Share your thoughts